Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Increased Enforcement On Functional Foods Triggers Class Action Risk

This article was originally published in The Tan Sheet

Executive Summary

Functional foods increasingly are vulnerable to costly class action lawsuits as regulators crack down on advertising claims in this previously oft-ignored category.

You may also be interested in...



Embria Studies FDA Expectations Before Successful EpiCor NDI

FDA’s formal acknowledgment of Embria’s NDI notification for EpiCor comes after the firm called FDA early in the process to discuss the pending notification and worked to understand the agency’s expectations fully. Kevin Boot, Embria’s regulatory counsel, recommends simple notifications that are “readable by everyone.”

Embria Studies FDA Expectations Before Successful EpiCor NDI

FDA’s formal acknowledgment of Embria’s NDI notification for EpiCor comes after the firm called FDA early in the process to discuss the pending notification and worked to understand the agency’s expectations fully. Kevin Boot, Embria’s regulatory counsel, recommends simple notifications that are “readable by everyone.”

Dannon's FTC Settlement Requires FDA Approval For Cold/Flu Immunity Claims

The Dannon Co. will drop "exaggerated" health claims for two yogurt products, including claims in advertising with actress Jamie Lee Curtis, under a settlement with the Federal Trade Commission.

Related Content

Topics

UsernamePublicRestriction

Register

ID036688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel